ImmunoCellular Therapeutics, Ltd Strengthens Executive Management Team With Appointment Of Dr. Steven Swanson To Lead Stem-To-T-Cell Program , PhD, as Senior Vice President, Research. Dr. Swanson will lead the Company's Stem-to-T-cell research program, which utilizes the patient's own hematopoietic stem cells to drive production of antigen-specific killer T-cells which then attack cancer cells.
http://ift.tt/1803MSz
http://ift.tt/1803MSz
No comments:
Post a Comment